262 related articles for article (PubMed ID: 18348682)
1. Targeting survivin in cancer therapy.
Pennati M; Folini M; Zaffaroni N
Expert Opin Ther Targets; 2008 Apr; 12(4):463-76. PubMed ID: 18348682
[TBL] [Abstract][Full Text] [Related]
2. Targeting survivin in cancer: patent review.
Kanwar JR; Kamalapuram SK; Kanwar RK
Expert Opin Ther Pat; 2010 Dec; 20(12):1723-37. PubMed ID: 21083520
[TBL] [Abstract][Full Text] [Related]
3. Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions.
Zaffaroni N; Daidone MG
Drug Resist Updat; 2002 Apr; 5(2):65-72. PubMed ID: 12135582
[TBL] [Abstract][Full Text] [Related]
4. Targeting survivin in cancer therapy: fulfilled promises and open questions.
Pennati M; Folini M; Zaffaroni N
Carcinogenesis; 2007 Jun; 28(6):1133-9. PubMed ID: 17341657
[TBL] [Abstract][Full Text] [Related]
5. Survivin as a target for new anticancer interventions.
Zaffaroni N; Pennati M; Daidone MG
J Cell Mol Med; 2005; 9(2):360-72. PubMed ID: 15963255
[TBL] [Abstract][Full Text] [Related]
6. A novel combination: ranpirnase and rosiglitazone induce a synergistic apoptotic effect by down-regulating Fra-1 and Survivin in cancer cells.
Ramos-Nino ME; Littenberg B
Mol Cancer Ther; 2008 Jul; 7(7):1871-9. PubMed ID: 18606715
[TBL] [Abstract][Full Text] [Related]
7. The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac.
Nikitakis NG; Scheper MA; Papanikolaou VS; Sauk JJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun; 107(6):826-36. PubMed ID: 19272804
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.
Pyrko P; Soriano N; Kardosh A; Liu YT; Uddin J; Petasis NA; Hofman FM; Chen CS; Chen TC; Schönthal AH
Mol Cancer; 2006 May; 5():19. PubMed ID: 16707021
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation.
Belyanskaya LL; Hopkins-Donaldson S; Kurtz S; Simões-Wüst AP; Yousefi S; Simon HU; Stahel R; Zangemeister-Wittke U
Int J Cancer; 2005 Dec; 117(5):755-63. PubMed ID: 15981204
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.
Kim S; Kang J; Qiao J; Thomas RP; Evers BM; Chung DH
J Pediatr Surg; 2004 Apr; 39(4):516-21. PubMed ID: 15065019
[TBL] [Abstract][Full Text] [Related]
11. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.
Capalbo G; Rödel C; Stauber RH; Knauer SK; Bache M; Kappler M; Rödel F
Strahlenther Onkol; 2007 Nov; 183(11):593-9. PubMed ID: 17960333
[TBL] [Abstract][Full Text] [Related]
12. Effect of downregulation of survivin expression on radiosensitivity of human epidermoid carcinoma cells.
Sah NK; Munshi A; Hobbs M; Carter BZ; Andreeff M; Meyn RE
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):852-9. PubMed ID: 17011457
[TBL] [Abstract][Full Text] [Related]
13. Livin/ML-IAP as a new target for cancer treatment.
Liu B; Han M; Wen JK; Wang L
Cancer Lett; 2007 Jun; 250(2):168-76. PubMed ID: 17218055
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy.
Wang S; Xu Y; Chan HF; Kim HW; Wang Y; Leong KW; Chen M
J Control Release; 2016 Oct; 240():454-464. PubMed ID: 27091696
[TBL] [Abstract][Full Text] [Related]
15. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
Zhang MC; Hu CP; Chen Q
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483
[TBL] [Abstract][Full Text] [Related]
16. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.
Hu H; Li GX; Wang L; Watts J; Combs GF; Lü J
Clin Cancer Res; 2008 Feb; 14(4):1150-8. PubMed ID: 18281549
[TBL] [Abstract][Full Text] [Related]
17. Oncogenes as novel targets for cancer therapy (part IV): regulators of the cell cycle and apoptosis.
Zhang Z; Li M; Rayburn ER; Hill DL; Zhang R; Wang H
Am J Pharmacogenomics; 2005; 5(6):397-407. PubMed ID: 16336004
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between survivin expression and chemosensitivity of human lung cancer cells].
Yang H; Fu JH; Hu Y; Huang WZ; Zheng B; Wang G
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1934-7. PubMed ID: 17923022
[TBL] [Abstract][Full Text] [Related]
19. Antisurvivin oligonucleotides inhibit growth and induce apoptosis in human medullary thyroid carcinoma cells.
Du ZX; Zhang HY; Gao DX; Wang HQ; Li YJ; Liu GL
Exp Mol Med; 2006 Jun; 38(3):230-40. PubMed ID: 16819281
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin-mediated inhibition of survivin increases sensitivity of head and neck squamous cell carcinoma cell lines to paclitaxel.
Khan Z; Khan N; Varma AK; Tiwari RP; Mouhamad S; Prasad GB; Bisen P
Curr Cancer Drug Targets; 2010 Nov; 10(7):660-9. PubMed ID: 20578991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
